The frequencies of CD4+ T cells expressing IL-6 (Figure 3B) or IL-9 (Figure 3C) were lower in melatonin-treated PBMCs from MG patients than in vehicle-treated cells. This evidence concerns the gene IL9 and myasthenia gravis.